{"id":"https://openalex.org/W2755624329","doi":"https://doi.org/10.1136/lupus-2017-000226","title":"Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-\u03b3 monoclonal antibody, in SLE subjects without or with lupus nephritis","display_name":"Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-\u03b3 monoclonal antibody, in SLE subjects without or with lupus nephritis","publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2755624329","doi":"https://doi.org/10.1136/lupus-2017-000226","mag":"2755624329","pmid":"https://pubmed.ncbi.nlm.nih.gov/29018537","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5604705"},"language":"en","primary_location":{"id":"doi:10.1136/lupus-2017-000226","doi":"https://doi.org/10.1136/lupus-2017-000226","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2017-000226","pdf_url":"https://lupus.bmj.com/content/lupusscimed/4/1/e000226.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Science & Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://lupus.bmj.com/content/lupusscimed/4/1/e000226.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085877701","display_name":"Michael J. Boedigheimer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J Boedigheimer","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David A Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A Martin","raw_affiliation_strings":["Amgen Inc., Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Seattle, Washington, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034623450","display_name":"Zahir Amoura","orcid":"https://orcid.org/0000-0003-0292-9043","observed_orcids":["https://orcid.org/0000-0003-0292-9043"]},"institutions":[{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Zahir Amoura","raw_affiliation_strings":["French National Reference Center for SLE, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"French National Reference Center for SLE, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France","institution_ids":["https://openalex.org/I4210121705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056786735","display_name":"Jorge S\u00e1nchez\u2010Guerrero","orcid":"https://orcid.org/0000-0003-2548-7276","observed_orcids":["https://orcid.org/0000-0003-2548-7276"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Jorge S\u00e1nchez-Guerrero","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008842237","display_name":"Juanita Romero\u2010D\u00edaz","orcid":"https://orcid.org/0000-0003-1782-5095","observed_orcids":["https://orcid.org/0000-0003-1782-5095"]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Juanita Romero-Diaz","raw_affiliation_strings":["Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210097900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082669130","display_name":"Alan Kivitz","orcid":"https://orcid.org/0000-0002-1045-1310","observed_orcids":["https://orcid.org/0000-0002-1045-1310"]},"institutions":[{"id":"https://openalex.org/I4210112965","display_name":"Altoona Center for Clinical Research","ror":"https://ror.org/022q8ez38","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210112965"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Kivitz","raw_affiliation_strings":["Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210112965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015927371","display_name":"Cynthia B. Aranow","orcid":"https://orcid.org/0000-0001-9299-0053","observed_orcids":["https://orcid.org/0000-0001-9299-0053"]},"institutions":[{"id":"https://openalex.org/I1327576362","display_name":"Feinstein Institute for Medical Research","ror":"https://ror.org/05dnene97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1302444339","https://openalex.org/I1327576362"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Aranow","raw_affiliation_strings":["Feinstein Institute for Medical Research, Manhasset, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Feinstein Institute for Medical Research, Manhasset, USA","institution_ids":["https://openalex.org/I1327576362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065649607","display_name":"Tak Mao Chan","orcid":"https://orcid.org/0000-0002-3495-4051","observed_orcids":["https://orcid.org/0000-0002-3495-4051"]},"institutions":[{"id":"https://openalex.org/I2800810863","display_name":"Queen Mary Hospital","ror":"https://ror.org/02xkx3e48","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I1294586568","https://openalex.org/I2800810863"]},{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["CN","HK"],"is_corresponding":false,"raw_author_name":"Tak Mao Chan","raw_affiliation_strings":["Queen Mary Hospital, University of Hong Kong, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary Hospital, University of Hong Kong, Hong Kong","institution_ids":["https://openalex.org/I2800810863","https://openalex.org/I889458895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045618801","display_name":"Yip Boon Chong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296788130","display_name":"University Malaya Medical Centre","ror":"https://ror.org/00vkrxq08","country_code":"MY","type":"healthcare","lineage":["https://openalex.org/I1296788130"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Yip Boon Chong","raw_affiliation_strings":["University Malaya Medical Centre, Kuala Lumpur, Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Malaya Medical Centre, Kuala Lumpur, Malaysia","institution_ids":["https://openalex.org/I1296788130"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kit Chiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kit Chiu","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christine Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Wang","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021351177","display_name":"Winnie Y. Sohn","orcid":"https://orcid.org/0000-0002-9469-1345","observed_orcids":["https://orcid.org/0000-0002-9469-1345"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Winnie Sohn","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112483147","display_name":"Gregory E. Arnold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory E Arnold","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111954224","display_name":"Michael A. Damore","orcid":"https://orcid.org/0000-0001-9083-6087","observed_orcids":["https://orcid.org/0000-0001-9083-6087"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A Damore","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043655994","display_name":"Andrew A. Welcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew A Welcher","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Barbara A Sullivan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara A Sullivan","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060612620","display_name":"Brian L. Kotzin","orcid":"https://orcid.org/0000-0002-6542-8599","observed_orcids":["https://orcid.org/0000-0002-6542-8599"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian L Kotzin","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016296602","display_name":"James B. Chung","orcid":"https://orcid.org/0000-0002-9775-0208","observed_orcids":["https://orcid.org/0000-0002-9775-0208"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James B Chung","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, California, USA","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5016296602"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":1950,"currency":"GBP","value_usd":2391},"apc_paid":{"value":1950,"currency":"GBP","value_usd":2391},"fwci":3.8727,"has_fulltext":true,"cited_by_count":65,"citation_normalized_percentile":{"value":0.9359116,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"4","issue":"1","first_page":"e000226","last_page":"e000226"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9890000224113464},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.902999997138977},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9890000224113464},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.6679999828338623},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9290000200271606},{"id":"https://openalex.org/keywords/il-18","display_name":"IL-18","score":0.859000027179718},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.9750000238418579},{"id":"https://openalex.org/keywords/selena-sledai","display_name":"SELENA-SLEDAI","score":0.8389999866485596},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8970000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9459663033485413},{"id":"https://openalex.org/C2779912601","wikidata":"https://www.wikidata.org/wiki/Q1621830","display_name":"Lupus nephritis","level":3,"score":0.8024374842643738},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7502546310424805},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7492820024490356},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6791601777076721},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5939784646034241},{"id":"https://openalex.org/C2780380361","wikidata":"https://www.wikidata.org/wiki/Q3618657","display_name":"Anti-dsDNA antibodies","level":4,"score":0.5799453258514404},{"id":"https://openalex.org/C2777058396","wikidata":"https://www.wikidata.org/wiki/Q401402","display_name":"Nephritis","level":2,"score":0.526692271232605},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.5110236406326294},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.48945653438568115},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4273381531238556},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.4224357604980469},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30699166655540466},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.26606276631355286},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1136/lupus-2017-000226","doi":"https://doi.org/10.1136/lupus-2017-000226","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2017-000226","pdf_url":"https://lupus.bmj.com/content/lupusscimed/4/1/e000226.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Science & Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4554391","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5604705","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5604705","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5604705","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Sci Med","raw_type":"Text"},{"id":"pmid:29018537","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29018537","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus science & medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1136/lupus-2017-000226","doi":"https://doi.org/10.1136/lupus-2017-000226","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2017-000226","pdf_url":"https://lupus.bmj.com/content/lupusscimed/4/1/e000226.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Science & Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2755624329.pdf","grobid_xml":"https://content.openalex.org/works/W2755624329.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1795316817","https://openalex.org/W1963756694","https://openalex.org/W1979524871","https://openalex.org/W1980842187","https://openalex.org/W2011190969","https://openalex.org/W2019362269","https://openalex.org/W2021657063","https://openalex.org/W2052004574","https://openalex.org/W2054080837","https://openalex.org/W2059316227","https://openalex.org/W2077594740","https://openalex.org/W2085570735","https://openalex.org/W2112698713","https://openalex.org/W2120630307","https://openalex.org/W2121171258","https://openalex.org/W2132743350","https://openalex.org/W2134429261","https://openalex.org/W2166327444","https://openalex.org/W2171121999","https://openalex.org/W2227157639","https://openalex.org/W2339641503","https://openalex.org/W2396623651","https://openalex.org/W2410579881","https://openalex.org/W2465446350","https://openalex.org/W2470127312","https://openalex.org/W2607741101","https://openalex.org/W2629609203","https://openalex.org/W3149947358","https://openalex.org/W4230766995","https://openalex.org/W4292083220","https://openalex.org/W4299714635"],"related_works":["https://openalex.org/W2371749983","https://openalex.org/W2120630307","https://openalex.org/W2786317321","https://openalex.org/W2107751463","https://openalex.org/W2339641503","https://openalex.org/W2154396830","https://openalex.org/W1924924816","https://openalex.org/W7100071380","https://openalex.org/W2917267656","https://openalex.org/W3204930621"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"safety,":[3],"pharmacokinetics":[4,238],"and":[5,50,97,141,147,164,170,186,199,239,259],"pharmacodynamics":[6],"of":[7,77,83,101,246],"anti-interferon":[8],"(IFN)-\u03b3":[9],"monoclonal":[10],"antibody":[11],"AMG":[12,41,58,162,179,234,253],"811":[13,42,59,163,180,235],"in":[14,93,103,173,202,262],"subjects":[15,34,51,126,145,152,174,203,214],"with":[16,20,52,133,148,177,193,204,213,252],"SLE":[17,129,144],"without":[18,35,130,146,175,215],"or":[19,45,48,62,65,176,224,228],"lupus":[21],"nephritis":[22],"(LN).":[23],"METHODS:":[24],"In":[25],"this":[26],"phase":[27],"Ib,":[28],"randomised,":[29],"multiple-dose":[30],"escalation":[31],"study":[32],"(NCT00818948),":[33],"LN":[36,53,263],"were":[37,54,139,159,168,196,256],"randomised":[38,55],"to":[39,56],"subcutaneous":[40,57],"(6,":[43],"20":[44],"60":[46,61],"mg)":[47,64],"placebo":[49,66],"(20,":[60],"120":[63],"every":[67],"four":[68],"weeks":[69],"for":[70,143],"three":[71],"total":[72],"doses.":[73],"Outcomes":[74],"included":[75],"incidence":[76],"adverse":[78],"events":[79],"(AEs);":[80],"pharmacokinetics;":[81],"levels":[82,185],"serum":[84],"proteins":[85],"(CXCL-10,":[86],"interleukin":[87],"18,":[88],"monocyte":[89],"chemotactic":[90],"protein-1);":[91],"changes":[92],"gene":[94],"transcript":[95],"profiles":[96,167],"clinical":[98,247],"parameters":[99],"(Safety":[100],"Estrogen":[102],"Lupus":[104,108],"Erythematosus":[105,109],"National":[106],"Assessment-Systemic":[107],"Disease":[110],"Activity":[111],"Index":[112],"(SELENA-SLEDAI)":[113],"scores,":[114,221],"proteinuria,":[115,222],"anti-double-stranded":[116],"DNA":[117],"(anti-dsDNA)":[118],"antibodies,":[119],"C3":[120,223],"complement,":[121],"C4":[122,225],"complement).":[123],"RESULTS:":[124],"Fifty-six":[125],"enrolled":[127],"(28":[128],"LN;":[131],"28":[132],"LN).":[134],"Baseline":[135],"mean":[136],"SELENA-SLEDAI":[137,220],"scores":[138],"2.2":[140],"12.0":[142],"LN,":[149,205],"respectively.":[150],"Most":[151],"reported":[153],"an":[154],"AE;":[155],"no":[156,244],"meaningful":[157],"imbalances":[158],"observed":[160],"between":[161],"placebo.":[165,194],"Pharmacokinetic":[166],"similar":[169],"mostly":[171],"dose-proportional":[172],"LN.":[178,216],"treatment":[181],"reduced":[182],"CXCL-10":[183],"protein":[184],"blood-based":[187],"RNA":[188],"IFN-\u03b3":[189],"Blockade":[190],"Signature":[191],"compared":[192,212],"Reductions":[195],"less":[197,257],"pronounced":[198,258],"not":[200,260],"sustained":[201,261],"even":[206],"at":[207],"the":[208],"highest":[209],"dose":[210],"tested,":[211],"No":[217],"effect":[218],"on":[219],"complement":[226],"levels,":[227],"anti-dsDNA":[229],"antibodies":[230],"was":[231],"observed.":[232],"CONCLUSION:":[233],"demonstrated":[236],"favourable":[237],"acceptable":[240],"safety":[241],"profile":[242],"but":[243],"evidence":[245],"impact.":[248],"IFN-\u03b3-associated":[249],"biomarkers":[250],"decreased":[251],"811;":[254],"effects":[255],"subjects.":[264],"TRIAL":[265],"REGISTRATION":[266],"NUMBER:":[267],"NCT00818948;":[268],"results.":[269]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2017-09-25T00:00:00"}